secondary endpoint

Related by string. secondary endpoints * SECONDARY . Secon dary . Secondary : Secondary School . Secondary Schools . Secondary Offering . Secondary Education / Endpoint . Endpoints . EndPoint : Secondary endpoints include . secondary efficacy endpoints . primary efficacy endpoint * Secondary endpoints included . specified secondary endpoints . Key secondary endpoints *

Related by context. Frequent words. (Click for all words.) 83 primary endpoint 81 secondary endpoints 80 primary efficacy endpoint 74 primary endpoints 66 p = #.# [002] 65 clinical endpoints 64 demonstrated statistically significant 64 free survival PFS 62 non inferiority 62 evaluable patients 62 statistically significant improvement 61 evaluable 61 p = #.# [004] 61 statistical significance 61 placebo p 60 P = .# 60 mg dose 60 placebo p = 60 statistically significant reduction 60 clinically meaningful 60 ACTEMRA 60 placebo 59 HbA1c levels 59 mg BID 58 pharmacodynamic 58 Phase 2b study 57 tolerability 57 treatment emergent adverse 57 sunitinib 57 HCV RNA 57 vandetanib 56 tiotropium 56 tumor shrinkage 56 p = 56 ticagrelor 56 statistically significant 56 placebo controlled 56 monotherapy 55 docetaxel 55 reach statistical significance 55 imatinib 55 plus ribavirin 55 randomized 55 etanercept 55 dose limiting toxicities 55 proteinuria 55 rivaroxaban 55 MACE 55 HbA1c 55 FOLFOX 55 endpoints 55 dyspnea 55 myocardial infarction 54 clinically relevant 54 tumor recurrence 54 sirolimus 54 disease progression 54 TAXUS 54 valsartan 54 tolerability profile 54 randomized placebo controlled 54 gefitinib 54 certolizumab pegol 54 randomization 54 Phase 2a clinical 54 LEVADEX 54 Phase 1b 54 plasma concentrations 54 unblinded 53 Phase IIb clinical 53 postoperatively 53 eculizumab 53 statistically significant differences 53 randomized double 53 Phase 2b clinical 53 pioglitazone 53 zoledronic acid 53 preoperative 53 budesonide 53 histologic 53 pharmacokinetics 53 left ventricular ejection 53 prognostic factors 53 53 febrile neutropenia 53 pharmacokinetic profile 53 rosuvastatin 53 Phase IIa clinical 53 n = 53 anastrozole 53 eGFR 53 pramipexole 53 confidence interval CI 53 FEV1 52 Zerenex 52 endpoint 52 infliximab 52 DSMB 52 randomized clinical 52 CYPHER R Stent 52 randomized controlled

Back to home page